Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 20, 2013, Pages 8188-8193

  Ramkissoon, Lori A ^a   Horowitz, Peleg M ^a,b,c,d   Craig, Justin M ^a   Ramkissoon, Shakti H ^a,b,d   Rich, Benjamin E ^a   Schumacher, Steven E ^a,c   McKenna, Aaron ^c   Lawrence, Michael S ^c   Bergthold, Guillaume ^a,c   Brastianos, Priscilla K ^a   Tabak, Barbara ^a,c   Ducar, Matthew D ^e   Van Hummelen, Paul ^e   MacConaill, Laura E ^b,e   Pouissant Young, Tina ^d   Cho, Yoon Jae ^f   Taha, Hala ^g   Mahmoud, Madeha ^g   Bowers, Daniel C ^h   Margraf, Linda ^h   Tabori, Uri ⁱ   Hawkins, Cynthia ⁱ   Packer, Roger J ^j   Hill, D Ashley ^j   Pomeroy, Scott L ^c,d   Eberhart, Charles G ^k   Dunn, Ian F ^b   Goumnerova, Liliana ^d   Getz, Gad ^c   Chan, Jennifer A ^l   Santagata, Sandro ^b,d,m   Hahn, William C ^a,c,e,m   Stiles, Charles D ^p   Ligon, Azra H ^b,m,o   Kieran, Mark W ^d,p   Beroukhim, Rameen ^a,c,e,n   Ligon, Keith L ^a,b,d,m,o   more..

^a Fenway Health   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e Department of Medical Oncology   (United States)

^f STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g CHILDREN S CANCER HOSPITAL   (Egypt)

^h UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁱ HOSPITAL FOR SICK CHILDREN   (Canada)

^j CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l UNIVERSITY OF CALGARY   (Canada)

^m HARVARD MEDICAL SCHOOL   (United States)

ⁿ Laboratory of Cancer Biology   (United States)

^o DANA FARBER CANCER INSTITUTE   (United States)

^p Pediatric Oncology   (United States)

more..

Author keywords

A myb; ACGH; Cancer

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MYBL1; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTOMA; CARBOXY TERMINAL SEQUENCE; CHILDHOOD CANCER; CHROMOSOME 6Q; CHROMOSOME 8Q; GENE DOSAGE; GENE DUPLICATION; GENE REARRANGEMENT; GENETIC ANALYSIS; GLIOMA; HUMAN; HUMAN TISSUE; PEDIATRIC LOW GRADE GLIOMA; PRIORITY JOURNAL;

A-MYB; ACGH; CANCER;

3T3 CELLS; ALLELES; ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMPARATIVE GENOMIC HYBRIDIZATION; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; MULTIGENE FAMILY; MUTATION; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS;

EID: 84877866746     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1300252110     Document Type: Article

References (35)

1. Horner MJRL, et al. (2009) SEER Cancer Statistics Review 1975-2006 (National Cancer Institute, Bethesda, MD).
2. Louis DN, et al. (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97-109. (Pubitemid 47103521)
3. Pfister S, et al. (2008) BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118(5):1739-1749. (Pubitemid 351632377)
4. Dias-Santagata D, et al. (2011) BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: Diagnostic and therapeutic implications. PLoS ONE 6(3):e17948.
5. Sievert AJ, et al. (2009) Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol 19(3):449-458.
6. Jones DT, et al. (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68(21):8673-8677.
7. Bar EE, Lin A, Tihan T, Burger PC, Eberhart CG (2008) Frequent gains at chromosome 7q34 involving BRAF in pilocytic astrocytoma. J Neuropathol Exp Neurol 67(9): 878-887.
8. Dougherty MJ, et al. (2010) Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. Neuro Oncol 12(7):621-630.
9. Schindler G, et al. (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121(3): 397-405.
10. Lin A, et al. (2012) BRAF alterations in primary glial and glioneuronal neoplasms of the central nervous system with identification of 2 novel KIAA1549:BRAF fusion variants. J Neuropathol Exp Neurol 71(1):66-72.
11. Tatevossian RG, et al. (2010) MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas. Acta Neuropathol 120(6):731-743.
12. Craig JM, et al. (2012) DNA fragmentation simulation method (FSM) and fragment size matching improve aCGH performance of FFPE tissues. PLoS ONE 7(6):e38881.
13. Kotliarov Y, et al. (2006) High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res 66(19):9428-9436. (Pubitemid 44623639)
14. Anonymous (2005) REMBRANDT home page (National Cancer Institute, Bethesda, MD).
15. Beroukhim R, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc Natl Acad Sci USA 104(50): 20007-20012.
16. Schwartzentruber J, et al. (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226-231.
17. Schiffman JD, et al. (2010) Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res 70(2): 512-519.
18. Tatevossian RG, et al. (2010) MAPK pathway activation and the origins of pediatric low-grade astrocytomas. J Cell Physiol 222(3):509-514.
19. Atlas TCG; Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455(7216):1061-1068.
20. McEvilly RJ, de Diaz MO, Schonemann MD, Hooshmand F, Rosenfeld MG (2002) Transcriptional regulation of cortical neuron migration by POU domain factors. Science 295(5559):1528-1532. (Pubitemid 34174009)
21. Shibata M, Nakao H, Kiyonari H, Abe T, Aizawa S (2011) MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J Neurosci 31(9):3407-3422.
22. Beroukhim R, et al. (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463(7283):899-905.
23. Paugh BS, et al. (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28(18):3061-3068.
24. Preusser M, et al. (2007) Angiocentric glioma: Report of clinico-pathologic and genetic findings in 8 cases. Am J Surg Pathol 31(11):1709-1718. (Pubitemid 350287569)
25. Persson M, et al. (2009) Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck. Proc Natl Acad Sci USA 106(44): 18740-18744.
26. Lei W, Rushton JJ, Davis LM, Liu F, Ness SA (2004) Positive and negative determinants of target gene specificity in myb transcription factors. J Biol Chem 279(28): 29519-29527. (Pubitemid 38915832)
27. Brastianos PK, et al. (2013) Genomic sequencing of meningiomas identifies oncogenic SMO and AKT1 mutations. Nat Genet 45(3):285-289.
28. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14):1754-1760.
29. Network TCGA; Cancer Genome Atlas Research Network (2011) Integrated genomic analyses of ovarian carcinoma. Nature 474(7353):609-615.
30. McKenna A, et al. (2010) The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297-1303.
31. DePristo MA, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491-498.
32. Berger MF, et al. (2011) The genomic complexity of primary human prostate cancer. Nature 470(7333):214-220.
33. Chapman MA, et al. (2011) Initial genome sequencing and analysis of multiple myeloma. Nature 471(7339):467-472.
34. Chiang DY, et al. (2009) High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat Methods 6(1):99-103.
35. Firestein R, et al. (2008) CDK8 is a colorectal cancer oncogene that regulates betacatenin activity. Nature 455(7212):547-551.